Dr. Steven Lee Bierlein, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 504 N Franklin St, Frankenmuth, MI 48734 Phone: 989-652-2626 Fax: 989-652-2643 |
Dr. Christopher David Zehnder, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 504 N Franklin St, Frankenmuth, MI 48734 Phone: 989-652-2626 Fax: 989-652-2643 |
Family Eye Care Ctr P C Optometrist Medicare: Medicare Enrolled Practice Location: 504 N Franklin St, Frankenmuth, MI 48734 Phone: 989-652-2626 Fax: 989-652-2643 |
Great Lakes Eye Institute Optometrist Medicare: Medicare Enrolled Practice Location: 406 W Genesee St, Frankenmuth, MI 48734 Phone: 989-652-2020 Fax: 989-652-9444 |
News Archive
For seniors, October is a month in which medications - particularly prescription meds - will likely be on their minds. Not only is October national "Talk About Prescriptions Month," but Oct. 15 marks the start of Medicare's Annual Election Period during which beneficiaries can disenroll from, switch or enroll into a Medicare Advantage or Part D plan.
Since Edison's first bulb, heat has been a mostly undesirable byproduct of light. Now researchers at Rice University are turning light into heat at the point of need, on the nanoscale, to trigger biochemical reactions remotely on demand.
According to a new study nearly 20% of American patients who receive an implantable cardioverter-defibrillator (ICD) may not need it. These ICDs when unnecessary could put the patients at higher risk of death and serious complications than patients who meet the criteria for the life-saving device say authors of the study published in the Jan. 5 issue of the Journal of the American Medical Association.
Blood and urine markers can indicate which patients with an abrupt kidney injury following heart surgery will experience progressive kidney problems, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
A University of Arkansas for Medical Sciences BioVentures startup company, InterveXion Therapeutics LLC, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break their addiction.
› Verified 8 days ago